$1.670
+0.129 (+7.74%)收盘时
OKYO 同业对比
In the context of the broader market, OKYO competes directly with industry leaders such as KLRS and RLYB. With a market capitalization of $87.64M, it holds a significant position in the sector. When comparing efficiency, OKYO's gross margin of N/A stands against KLRS's N/A and RLYB's 100.00%. Such benchmarking helps identify whether OKYO Pharma Ltd is trading at a premium or discount relative to its financial performance.
OKYO Pharma Ltd 财务表现
The company has a negative P/E ratio of -6.26 and a price-to-sales ratio of 0, indicating it is not generating revenue relative to its market cap, which is concerning for long-term viability.
Financials
No data
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。